Nexthera Capital »

Anaptysbio Inc Common shares owned by Nexthera Capital

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $679k 12k 56.46

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Tang Capital Management
Vanguard Group
Boxer Capital
First Light Asset Management
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management
Point72 Asset Management
Palo Alto Investors
Dimensional Fund Advisors
Eventide Asset Management
Millennium Management
Franklin Resources
5AM Venture Management
Blackstone Group

View all funds holding Anaptysbio Inc Common